Products

Certinal

Uses AI

Consent & Compliance Platform for the DPDP Act

certinal.com Sales / Proposals, Quotes & E-signature

AI Benchmark
Desktop
Mobile
Monthly visits
40.2K
Up25.5%MoMOct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Certinal
@certinal· 15 followers
Launched
2y ago
2024-05-05 · Est.

Traffic

Monthly visitsData through Oct 2026
Events21 changes

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Enterprise Grade E-Signature Suite for Large Enterprises

    May 5, 2024 · 2y agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct53%
  • Social19%
  • Organic Search15%
  • Paid Search7%
  • Other6%

Countries

  • United States37%
  • India12%
  • Slovakia8%
  • United Kingdom6%
  • Canada5%

Search

Domain authority —Domain registered 2020-11-02

KeywordMonthly volume
certinal500
online intake consent forms reddit cheapest260
certinal esign80
centrinal50
reason for generating key pairs—

Traffic data: Vaneform

Pricing

User Plans
Contact sales
eSign Enterprise Plan
Contact sales
100MB File Size Limit
Sandbox
Unknown
Enterprise Plan
Contact sales

Trial: None · Enterprise custom tier · Observed 2026-11-04 · Pricing page

Pages & changes

Tracked since 2024-05-05

Key pages

Weekly snapshots
certinal.com/ Snapshot 2026-11-04

Changes

  1. Nov 1 · 15d ago

    Homepage headline (H1) changed to “Compliant Consent For Every Patient Interaction”Positioning

    Enterprise Grade Digital Signature Suite→Compliant Consent For Every Patient Interaction

    At the time: 40.2K visits/mo20 concurrent moves
  2. Nov 1 · 15d ago

    Adopted technology: Apple iCloud MailFeatures

    —→Apple iCloud Mail

    At the time: 40.2K visits/mo20 concurrent moves
  3. Nov 1 · 15d ago

    Adopted technology: CloudwaysFeatures

    —→Cloudways

    At the time: 40.2K visits/mo20 concurrent moves
  4. Nov 1 · 15d ago

    Removed technology: DemandbaseFeatures

    Demandbase→—

    At the time: 40.2K visits/mo20 concurrent moves
  5. Nov 1 · 15d ago

    Adopted technology: Facebook PixelFeatures

    —→Facebook Pixel

    At the time: 40.2K visits/mo20 concurrent moves
  6. Nov 1 · 15d ago

    Adopted technology: Google Font APIFeatures

    —→Google Font API

    At the time: 40.2K visits/mo20 concurrent moves

Design

First-screen visual analysis & :root CSS

Soft & Friendly (Light canvas, airy density) featuring centered headline + cta layout and pure typography & geometry visuals.

First-screen preview · click to zoom

First-screen pitch & conversion flow

“Consent & compliance built for the DPDP Act”

Centered Headline + CTA hero structure paired with book demo / contact sales CTA and user count, rating, or key metrics.

Conversion path: Centered Headline + CTA + Pure Typography & Geometry → Book Demo / Contact Sales · Trust bar: User Count, Rating, or Key Metrics

Palette · click to copy

5-D design score7.3 / 10
Typography
7.0
Color & Contrast
8.0
Layout & Spacing
8.0
Craft & Polish
7.0
Distinctiveness
6.0

Structure

Fonts
Inter
Primary visual
Pure Typography & Geometry
Social proof
User Count, Rating, or Key Metrics
Navigation
Full-Width Top Bar
Theme & density
Light · Airy
Corners & depth
Pill · With shadow
Preview full AI design brief (includes :root CSS variables & layout rules)Style tokens only; never copy brand names, logos, copy, or images
# Design Brief: Soft & Friendly (with Gradient Glow)

Warm low-saturation pastels, generous rounded corners, and approachable illustrations.

## Design Tokens

```css
:root {
  --background: #f7fbf4;
  --surface: #ffffff;
  --foreground: #111111;
  --muted-foreground: #5e6b64;
  --accent: #c6ef4a;
  --radius: 9999px;
  --font-heading: "Inter", ui-sans-serif, system-ui, sans-serif;
  --font-body: "Inter", ui-sans-serif, system-ui, sans-serif;
}
```

Color area ratio: Background #F7FBF4 (~52%) · Surface #FFFFFF (~18%) · Text #111111 (~10%) · Muted Text #5E6B64 (~8%) · Accent #C6EF4A (~12%). Background and surface dominate the canvas; reserve the accent color for primary buttons and active states.

## Layout & Conversion Structure

- Hero layout: Centered Headline + CTA
- Navigation: Full-Width Top Bar
- Theme & density: Light · Airy
- Border radius & elevation: Pill; use elevation shadows to separate layers
- Primary visual medium: Pure Typography & Geometry
- Conversion CTA: Book Demo / Contact Sales · Trust bar uses User Count, Rating, or Key Metrics
- Headline hook: Category Positioning Anchor
- Hero components: Metrics Strip
- Spatial layout notes: Centered Headline + CTA hero structure paired with book demo / contact sales CTA and user count, rating, or key metrics.
- Visual summary: Soft & Friendly (Light canvas, airy density) featuring centered headline + cta layout and pure typography & geometry visuals.

## Avoid

- Harsh pure-black backgrounds
- Sharp 0px corners
- Cold technical jargon in hero copy

Implement the UI following the design tokens and layout specifications above: use only these color variables, and reserve the accent color strictly for primary actions and active states. Adopt only this visual style—never copy any reference product’s brand name, logo, copy, or imagery.

Questions & evidence

How much does Certinal cost?
User Plans: Contact sales; eSign Enterprise Plan: Contact sales; Sandbox: Unknown; Enterprise Plan: Contact sales. Observed 2026-11-04. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Certinal get?
Vaneform estimates 40.2K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Certinal and what platforms does it support?
Certinal is catalogued under Proposals, Quotes & E-signature: Consent & Compliance Platform for the DPDP Act. Supported platforms: API.

Related products in this category

Sales / Proposals, Quotes & E-signature

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.